<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Purinergic Signal</journal-id>
      <journal-title>Purinergic Signalling</journal-title>
      <issn pub-type="ppub">1573-9538</issn>
      <issn pub-type="epub">1573-9546</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18368535</article-id>
      <article-id pub-id-type="pmc">2246002</article-id>
      <article-id pub-id-type="publisher-id">9095</article-id>
      <article-id pub-id-type="doi">10.1007/s11302-008-9095-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Brief Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The inflammatory effects of UDP-glucose in N9 microglia are not mediated by P2Y14 receptor activation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Brautigam</surname>
            <given-names>Vielska M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dubyak</surname>
            <given-names>George R.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Crain</surname>
            <given-names>Jessica M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Watters</surname>
            <given-names>Jyoti J.</given-names>
          </name>
          <address>
            <phone>+1-608-262-1016</phone>
            <fax>+1-608-263-3926</fax>
            <email>jjwatters@wisc.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Comparative Biosciences, University of Wisconsin, 2015 Linden Dr., Madison, WI 53706 USA </aff>
        <aff id="Aff2"><label>2</label>Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH USA </aff>
        <aff id="Aff3"><label>3</label>Program in Molecular and Cellular Biology, University of Wisconsin, Madison, WI 53706 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>2</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2008</year>
      </pub-date>
      <volume>4</volume>
      <issue>1</issue>
      <fpage>73</fpage>
      <lpage>78</lpage>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>1</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>1</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer Science+Business Media B.V. 2008</copyright-statement>
      </permissions>
      <abstract>
        <p>In this study we evaluated the functionality and inflammatory effects of P2Y14 receptors in murine N9 microglia. The selective P2Y14 receptor agonist UDP-glucose (UDPG) derived from microbial sources dose dependently stimulated expression of cyclooxygenase-2 and inducible nitric oxide synthase, and potentiated the effects of bacterial lipopolysaccharide on nitric oxide production. However, another selective P2Y14 receptor agonist, UDP-galactose, did not affect these endpoints either alone or in combination with lipopolysaccharide. Interestingly, synthetic UDPG also had no detectable pro-inflammatory effects, although P2Y14 receptors are both expressed and functional in N9 microglia. While synthetic UDPG decreased levels of phosphorylated cyclic AMP response element binding protein, an effect that was blocked by pertussis toxin, the pro-inflammatory effects of microbial-derived UDPG were insensitive to pertussis toxin. These data suggest that the pro-inflammatory effects of microbial-derived UDPG are independent of P2Y14 receptors and imply that microbial-derived contaminants in the UDPG preparation may be involved in the observed inflammatory effects.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Cyclic AMP response element binding protein (CREB)</kwd>
        <kwd>Cyclooxygenase-2 (COX-2)</kwd>
        <kwd>Inducible nitric oxide synthase (iNOS)</kwd>
        <kwd>Microglia</kwd>
        <kwd>Pertussis toxin (PTX)</kwd>
        <kwd>P2Y14</kwd>
        <kwd>UDP galactose</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media B.V. 2008</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
</article>
</pmc-articleset>